CJC-1295 Whitout DAC

CJC-1295 without DAC is a synthetic analog of growth hormone-releasing hormone (GHRH), engineered to stimulate the secretion of growth hormone (GH) in non-human research subjects. Unlike its DAC counterpart, this form lacks the Drug Affinity Complex, resulting in a shorter half-life, typically around 30 minutes to a few hours in test subjects. Despite this reduced duration of activity, it effectively binds to GHRH receptors, triggering a cascade of signaling events that enhance pulsatile GH release.

In laboratory studies, CJC-1295 without DAC has demonstrated utility in investigating the GH/IGF-1 axis, protein synthesis, and tissue repair processes. Additionally, this version of the peptide provides insights into receptor-binding kinetics, enzymatic degradation, and short-term effects on cellular metabolism in test subjects.

The absence of DAC allows for a more transient yet targeted approach to studying endocrine function, making it a valuable tool for experiments requiring immediate but time-limited modulation of GH levels in controlled research environments in non-human research subjects.